|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-10
|
|
pubmed:abstractText |
The perioperative management of patients receiving oral anticoagulation therapy (OAC) who undergo pacemaker (PM) and defibrillator (ICD) surgery remains controversial. Low-molecular-weight heparin (LMWH) is often used; however, wound hematoma is a common complication.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1540-8159
|
|
pubmed:author |
pubmed-author:BaranchukAdrianA,
pubmed-author:ConnollyStuart JSJ,
pubmed-author:EikelboomJohnJ,
pubmed-author:EvansGeoffG,
pubmed-author:HealeyJeff SJS,
pubmed-author:MorilloCarlos ACA,
pubmed-author:NairGirish MGM,
pubmed-author:RibasSebastianS,
pubmed-author:RobinsonMarleneM,
pubmed-author:SchulmanSamS,
pubmed-author:TurpieAlexander GAG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
378-82
|
|
pubmed:meshHeading |
pubmed-meshheading:19272069-Aged,
pubmed-meshheading:19272069-Anticoagulants,
pubmed-meshheading:19272069-Defibrillators, Implantable,
pubmed-meshheading:19272069-Female,
pubmed-meshheading:19272069-Hematoma,
pubmed-meshheading:19272069-Heparin, Low-Molecular-Weight,
pubmed-meshheading:19272069-Humans,
pubmed-meshheading:19272069-Male,
pubmed-meshheading:19272069-Pacemaker, Artificial,
pubmed-meshheading:19272069-Postoperative Care,
pubmed-meshheading:19272069-Surgical Wound Dehiscence,
pubmed-meshheading:19272069-Thrombosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
|
|
pubmed:affiliation |
Department of Medicine, McMaster University, 237 Barton Street East, Hamilton, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
